Similar Items: Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015–2022 Influenza Seasons
- Antiviral Resistance in Influenza: Clinical and Public Health Implications
- Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany
- Correction to “Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024‐2025 Winter Season.”
- Secondary organizing pneumonia complicating influenza B
- Hypertransaminasemia Is a Marker of Severity in Children Hospitalized for Influenza
- Correction to “Effectiveness of Influenza Vaccines in Italy in the 2024/2025 Season: A Nationwide, Test‐Negative Design Study Based on Surveillance Records”